Profilo
Attualmente, Edmund Doherty occupa la posizione di vicepresidente degli affari medici per Reata Pharmaceuticals, Inc. Ha ricevuto un dottorato dalla Creighton University.
Precedenti posizioni note di Edmund Doherty
| Società | Posizione | Fine |
|---|---|---|
| REATA PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 01/12/2021 |
Formazione di Edmund Doherty
| Creighton University | Doctorate Degree |
Esperienze
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 1 |
|---|---|
Reata Pharmaceuticals, Inc.
 Reata Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Reata Pharmaceuticals, Inc. is a clinical stage biopharmaceutical company, which engages in identifying, developing, and commercializing pharmaceutical products. Its product candidates are bardoxolone methyl and omaveloxolone, which activate the transcription factor Nrf2 to restore mitochondrial function, reduce oxidative stress, and resolve inflammation. The company was founded by J. Warren Huff in 2002 and is headquartered in Plano, TX. | Health Technology |
- Borsa valori
- Insiders
- Edmund Doherty
